Eftilagimod Alpha (Soluble LAG-3) & Pembrolizumab in First-Line Recurrent or Metastatic Head & Neck Squamous Cell Carcinoma
Chair: Amanda Psyrri, Greece; Presenter: Robert Metcalf, UK; Discussant: Marc Oliva, Spain; AACR Expert Commentary: Jong Chul Park, USA